1. OP0075 Impact of Different Infliximab Dose Regimens on Treatment Response and Drug Survival in 462 Patients with PSA. Results from the Nationwide Registries Danbio and Icebio. (10th June 2014) Authors: Glintborg, B.; Gudbjornsson, B.; Krogh, N.S.; Omerovic, E.; Manilo, N.; Holland-Fischer, M.; Lindegaard, H.; Loft, A.G.; Nordin, H.; Johnsen, L.; Oeftiger, S.F.; Hansen, A.; Rasmussen, C.; Grondal, G.; Geirsson, A.J.; Hetland, M.L. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗